Sibutramine effectively promotes weight loss in obese children and improves blood pressure and heart rate, according to the results of a randomized, double-blind, placebo-controlled trial published in the June 18 Early Release issue of Pediatrics. Join discussion...

A new weight loss drug designed for obese adults failed to win approval from an FDA advisory panel Wednesday, mainly because of fears that it can lead to depression and suicidal thoughts in some patients. Join discussion...

The Woolcock Institute of Medical Research is investigating the link between testosterone, obesity and sleep apnea. Join discussion...